Source:http://linkedlifedata.com/resource/pubmed/id/15870547
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2005-5-4
|
pubmed:abstractText |
The relationship between haemostatic factors and recurrent cardiovascular events was investigated in patients enrolled with acute coronary syndrome (acute non-Q myocardial infarction or unstable angina pectoris). One hundred and fifteen patients, aged 64 +/- 10 years, were included in the study. Haemostatic parameters [prothrombin time, activities of factor VII, factor VIII, factor X, antithrombin (AT) and protein C (PC), and concentrations of free protein S, fibrinogen, D-dimer, prothrombin fragment 1+2, and thrombin-antithrombin complex] were measured four times: within 48 h of hospitalization, at discharge (days 5-8), at 3 months and after 1 year. Screening for factor V Leiden mutation was also performed. Patients were followed for cardiovascular endpoints (new or refractory unstable angina pectoris, non-fatal myocardial infarction, stroke, or death) for an average of 555 days. Of all patients, 35 had an endpoint during the follow-up ("endpoint" group) and 80 patients did not ("no endpoint" group). Analysing the whole follow-up period, PC (P < 0.01) and AT (P < 0.01) were lower in the "endpoint" than in the "no endpoint" group. With 50% percentiles at enrollment, the odds ratio for getting an endpoint in the low (cut-off value < 100%) versus high PC group was 2.72 (95% confidence interval, 1.18-6.29; P < 0.05). Lower levels of AT (P < 0.05) and PC (P < 0.05) during the whole follow-up were associated with a shorter event-free time. In conclusion, lower PC and AT values, even within the normal range, seem to be associated with elevated risk for recurrent cardiovascular events and shorter event-free time in acute coronary syndrome patients.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0957-5235
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
275-80
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15870547-Aged,
pubmed-meshheading:15870547-Angina Pectoris,
pubmed-meshheading:15870547-Antithrombin III,
pubmed-meshheading:15870547-Cardiovascular Diseases,
pubmed-meshheading:15870547-Death,
pubmed-meshheading:15870547-Disease-Free Survival,
pubmed-meshheading:15870547-Follow-Up Studies,
pubmed-meshheading:15870547-Hemostasis,
pubmed-meshheading:15870547-Humans,
pubmed-meshheading:15870547-Middle Aged,
pubmed-meshheading:15870547-Myocardial Infarction,
pubmed-meshheading:15870547-Odds Ratio,
pubmed-meshheading:15870547-Protein C,
pubmed-meshheading:15870547-Recurrence,
pubmed-meshheading:15870547-Risk,
pubmed-meshheading:15870547-Stroke
|
pubmed:year |
2005
|
pubmed:articleTitle |
Low normal level of protein C or of antithrombin increases risk for recurrent cardiovascular events.
|
pubmed:affiliation |
Department of Medicine, Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland. markuspelkonen@suomi24.fi
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|